<DOC>
	<DOCNO>NCT00975117</DOCNO>
	<brief_summary>The purpose study determine whether administration dietary supplement Spermotrend improve spermatogenesis parameter subject male infertility unrelated major testicular condition . The duration double-blind placebo control phase 3 clinical trial 24 week . The estimated number male infertility recruit randomize study 86 .</brief_summary>
	<brief_title>Spermotrend Treatment Male Infertility</brief_title>
	<detailed_description />
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Infertility , Male</mesh_term>
	<criteria>Male infertility unrelated major testicular condition Must least one alter seminal parameter . Signed informed consent Hydrocele , varicocele , orchitis , epididymitis , irradiation Chemotherapy . Previously treat cure testicular condition . Nontransmissible chronic disease Use antioxidant agent within 6 month . Use vitamins within 6 month . Use antiinflammatory drug within 6 month . Use hormones prescribe andrologist within 6 month Positive serology/HIV Leukocytospermia</criteria>
	<gender>Male</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>Dietary supplement</keyword>
	<keyword>male infertility</keyword>
	<keyword>spermatogenesis</keyword>
</DOC>